NetworkNewsBreaks

WednesdaySep 04, 2024 3:55 pm

NetworkNewsBreaks – MoneyShow Announces Agenda for This Month’s Virtual Expo on Income, Growth, Value

MoneyShow, a leading producer of financial conferences for affluent investors, active traders and financial advisors, has announced its upcoming MoneyShow Virtual Expo – Income, Growth, and Value; the event is slated for Sept. 17–19, 2024, in an entirely digital format. According to the announcement, MoneyShow conferences have built a reputation for offering industry flagship events that offer world-class educational opportunities in trading and investing domains. MoneyShow Virtual Expo state-of-the-art digital platform enables attendees to watch market analysis presentations and receive timely portfolio recommendations; the upcoming event agenda includes more than 30 live sessions and invaluable opportunities to directly engage with industry…

Continue Reading

WednesdaySep 04, 2024 3:42 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Completes First Shipment of Vehicles Purchased by Volt Mobility through $210M PO

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, announced the initial shipment of vehicles to fulfill a $210 million purchase contract with Volt Mobility, which is based in the United Arab Emirates (“UAE”). Volt has purchased 3,000 Mullen Class 1 and Class 3 EV cargo vans and trucks to be delivered over a 16-month period. The initial shipment of vehicles represents the first phase of the multivehicle agreement between Mullen and Volt Mobility. Volt plans to lease these vehicles to its corporate customers in the region, including UPS, DHL and FedEx. “We’re happy to announce we have shipped the…

Continue Reading

WednesdaySep 04, 2024 3:32 pm

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Developing Fast-Track-Designated Treatment for Fibromyalgia

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, is developing TNX-102 SL, a new nonaddictive treatment for fibromyalgia, the prototypic nociplastic pain syndrome. According to a recent post, research into the causes and nature of pain is increasing; the post observed that there were more than 400 scientific presentations at the 2024 Word Congress on Pain, which was held Aug. 6–9, 2024, and was sponsored by the International Association for the Study of Pain. The article noted there different types of pain have been identified: nociceptive pain, neuropathic pain and nociplastic pain.…

Continue Reading

WednesdaySep 04, 2024 3:25 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating in the upcoming H.C. Wainwright 26th Annual Global Investment Conference. The event is slated for Sept. 9–11, 2024, in New York. According to the announcement, CEO John Climaco will present at the event; his presentation will be available as an on-demand video webcast beginning Sept. 9 at 7 a.m. ET. Climaco will also be available to participate in one-on-one meetings. To view the on-demand webcast, visit https://nnw.fm/Bfoz8 To view the full…

Continue Reading

WednesdaySep 04, 2024 3:17 pm

NetworkNewsBreaks – Lucid Group Inc. (NASDAQ: LCID) to Host Technology and Manufacturing Day

Lucid Group (NASDAQ: LCID), maker of the world's most-advanced electric vehicles, has announced a Technology & Manufacturing Day. The company will host the event on Sept. 10, 2024, which will be livestreamed beginning at 8 a.m. PT from the company’s Arizona factory. According to the announcement, the event will showcase the company’s Lucid Gravity SUV and will cover enabling technologies as well as provide an analysis of the cost effectiveness of manufacturing these innovations. Those invited to attend the event in person will also participate in a factory tour and have the opportunity to ride in the both the Lucid…

Continue Reading

WednesdaySep 04, 2024 2:16 pm

NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Enters into Public Offering Agreement Estimated to Total $4.45M

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, has entered into a placement agency agreement. The agreement is for the purchase and sale of 8,106,584 shares of its common stock (or prefunded warrants in lieu thereof). The shares are offered at $0.55 per share (or $0.549 per prefunded warrant in lieu thereof). According to the announcement, the offering is expected to close on or about Sept. 5, 2024. Gross proceeds of the offering, which will be subject to customary closing conditions, are estimated to be approximately $4.45 million before deduction of…

Continue Reading

WednesdaySep 04, 2024 2:05 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Makes Commitment to Transparency and Regulatory Compliance in Brazil

Meta (NASDAQ: META), known for its significant presence in the social media landscape through platforms like Facebook and Instagram, has recently made headlines with its commitment to transparency in Brazil. The company’s decision to inform Brazilian users about the use of their personal data for training generative artificial intelligence (“AI”) technologies marks a pivotal moment in the ongoing dialogue about data privacy and AI ethics. This move comes in the wake of a directive from Brazil’s National Data Protection Authority (“ANPD”), which underscores the increasing global attention on how tech companies manage and utilize user data. The directive from the…

Continue Reading

WednesdaySep 04, 2024 1:53 pm

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, is reporting its Q2 2024 financial results for the period ending July 31, 2024. According to the report, the company ended the quarter in a strong cash position, reinforcing its ability to advance the development of its lead product, AVERSA(TM) Fentanyl, with a New Drug Application (“NDA”) submission planned for the first half of 2025. The report showed Nutriband with cash reserves of $6.75 million, supporting the company's ongoing development and commercialization efforts for AVERSA Fentanyl; total assets are valued at $13.63 million, with stockholders' equity amounting to $12.5 million. The…

Continue Reading

WednesdaySep 04, 2024 1:37 pm

NetworkNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Doses Five New Patients in UK ACHIEVE Phase 2b Trial

TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has dosed five new patients in the ongoing ACHIEVE phase 2b trial in the United Kingdom. According to the announcement, that brings the total number of patients dosed to six; five patients have received a second dose and two patients have received a third dose. The announcement noted that there are four possible doses at the higher dose level, with each 5mL dose containing up to 230 million gamma delta T cells. New patients will continue to be identified, screened and enrolled into…

Continue Reading

WednesdaySep 04, 2024 12:55 pm

NetworkNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Reports Early Return on Investment at SASB Gas Field, Shares August Performance

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye, today provided a production update for the SASB gas field, noting that the SASB revitalization program realized the complete payback of recent perforation costs. According to the update, the Guluc-2, South Akcakoca-2, West Akcakoca-1 and Akcakoca-3 wells started production over a staggered period from July 9 to July 28 and have already produced 140MMcf, representing a 35-day payoff of the recent perforation CAPEX. Gas production from the Akcakoca platform has averaged 4.6 MMcf/d since the…

Continue Reading